An Open Label, Multi-centre, Non-interventional Post-marketing Surveillance (PMS) to Monitor the Safety and Efficacy of ZIAGEN® Administered in Korean Patients According to the Prescribing Information

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source

ClinicalTrials.gov

Source record ID

NCT01205243

Title field or adapter rule

protocolSection.identificationModule.officialTitle

Ingested At

2026-04-28T10:36:54.075608+00:00

Published At

2018-06-19T00:00:00+00:00

Record Updated At

2018-06-19

Timestamp Basis

source retrieval time was not retained by the feed adapter

Date limitation

source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions

["Infection, Human Immunodeficiency Virus I"]

protocolSection.statusModule.lastUpdatePostDateStruct.date

"2018-06-19"

protocolSection.identificationModule.nctId

"NCT01205243"

protocolSection.identificationModule.officialTitle

"An Open Label, Multi-centre, Non-interventional Post-marketing Surveillance (PMS) to Monitor the Safety and Efficacy of ZIAGEN\u00ae Administered in Korean Patients According to the Prescribing Information"

protocolSection.statusModule.overallStatus

"COMPLETED"

protocolSection.designModule.phases

[]

protocolSection.statusModule.resultsFirstPostDateStruct.date

""

Study condition terms

• Infection, Human Immunodeficiency Virus I (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.